Aspiriant LLC’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$324K Sell
1,024
-161
-14% -$50.4K 0.01% 308
2026
Q2
$355K Sell
1,185
-87
-7% -$24.2K 0.01% 296
2026
Q1
$347K Buy
1,272
+180
+16% +$51.5K 0.01% 260
2025
Q4
$314K Buy
1,092
+173
+19% +$48.3K 0.01% 270
2025
Q3
$238K Buy
+919
New +$231K 0.01% 279
2025
Q2
– Sell
-986
Closed -$261K – 317
2025
Q1
$261K Hold
986
– – 0.01% 252
2024
Q4
$250K Sell
986
-47
-5% -$12.7K 0.01% 255
2024
Q3
$292K Buy
1,033
+190
+23% +$52.8K 0.01% 236
2024
Q2
$224K Hold
843
– – 0.01% 263
2024
Q1
$228K Hold
843
– – 0.01% 293
2023
Q4
$211K Buy
+843
New +$200K 0.01% 290
2022
Q2
– Sell
-866
Closed -$220K – 290
2022
Q1
$220K Buy
+866
New +$214K 0.01% 259

Other funds holding VHT

Aspiriant LLC's VHT Position: Q3 2026 in Review

Aspiriant LLC reduced its Vanguard Health Care ETF (VHT) stake by 14% in Q3 2026, selling an estimated $50.4K and leaving 1,024 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #308.

Aspiriant LLC first reported a position in VHT in Q1 2022 and has held it in 12 quarters since. The position peaked at $355K in Q2 2026. 363 funds tracked by Wall St. Rank hold VHT as of Q3 2026.

  • Aspiriant LLC held 1,024 shares of Vanguard Health Care ETF worth $324K as of Q3 2026.
  • Aspiriant LLC sold 161 Vanguard Health Care ETF shares in Q3 2026, an estimated $50.4K.
  • Vanguard Health Care ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #308 holding.
  • Aspiriant LLC first reported a position in Vanguard Health Care ETF in Q1 2022 and has held it in 12 quarters since.
  • Aspiriant LLC's Vanguard Health Care ETF position peaked at $355K in Q2 2026.
  • 363 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.